您当前的位置:
首页 >
文章列表页 >
Defective EMC1 drives abnormal retinal angiogenesis via Wnt/β-catenin signaling and may be associated with the pathogenesis of familial exudative vitreoretinopathy
Full Length Articles | 更新时间:2024-02-04
    • Defective EMC1 drives abnormal retinal angiogenesis via Wnt/β-catenin signaling and may be associated with the pathogenesis of familial exudative vitreoretinopathy

    • Defective EMC1 drives abnormal retinal angiogenesis via Wnt/β-catenin signaling and may be associated with the pathogenesis of familial exudative vitreoretinopathy

    • Genes & Diseases   2023年1卷第6期 页码:2572-2585
    • DOI:10.1016/j.gendis.2022.10.003    

      中图分类号:
    • 纸质出版日期:2023,

      网络出版日期:2023-11-1,

    扫 描 看 全 文

  • Defective EMC1 drives abnormal retinal angiogenesis via Wnt/β-catenin signaling and may be associated with the pathogenesis of familial exudative vitreoretinopathy[J]. Genes & Diseases, 2023,1(6):2572-2585. DOI: 10.1016/j.gendis.2022.10.003.

    Shujin Li, Mu Yang, Rulian Zhao, et al. Defective EMC1 drives abnormal retinal angiogenesis via Wnt/β-catenin signaling and may be associated with the pathogenesis of familial exudative vitreoretinopathy[J]. Genes & Diseases, 2023,1(6):2572-2585. DOI: 10.1016/j.gendis.2022.10.003.

  •  
  •  
查看原文

0

浏览量

0

下载量

0

CSCD

文章被引用时,请邮件提醒。
提交
工具集
下载
参考文献导出
分享
收藏
添加至我的专辑

相关文章

The journey towards physiology and pathology: Tracing the path of neuregulin 4
HIF-1α signaling: Essential roles in tumorigenesis and implications in targeted therapies
Mechanistic insight into lysyl oxidase in vascular remodeling and angiogenesis
LncRNA H19 mediates BMP9-induced angiogenesis in mesenchymal stem cells by promoting the p53-Notch1 angiogenic signaling axis
JAG1 enhances angiogenesis in triple-negative breast cancer through promoting the secretion of exosomal lncRNA MALAT1

相关作者

Liang Guo
Wangjing Mu
Hongyang Luo
Jieying Zhu
Min Chen
Hongling Peng
Can Ye
Yating Deng

相关机构

School of Exercise and Health and Shanghai Frontiers Science Research Base of Exercise and Metabolic Health, Shanghai University of Sport
Hunan Engineering Research Center of Cell Immunotherapy for Hematopoietic Malignancies, The Second Xiangya Hospital, Central South University
Hunan Key Laboratory of Tumor Models and Individualized Medicine, The Second Xiangya Hospital, Central South University
Department of Hematology, The Second Xiangya Hospital, Central South University
Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics
0